IL146454A0 - METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY - Google Patents

METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY

Info

Publication number
IL146454A0
IL146454A0 IL14645400A IL14645400A IL146454A0 IL 146454 A0 IL146454 A0 IL 146454A0 IL 14645400 A IL14645400 A IL 14645400A IL 14645400 A IL14645400 A IL 14645400A IL 146454 A0 IL146454 A0 IL 146454A0
Authority
IL
Israel
Prior art keywords
present
sample
hcg
subject
provides
Prior art date
Application number
IL14645400A
Other languages
English (en)
Original Assignee
Univ Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Columbia filed Critical Univ Columbia
Publication of IL146454A0 publication Critical patent/IL146454A0/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57449—Specifically defined cancers of ovaries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/814—Pregnancy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y10S436/818—Human chorionic gonadotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL14645400A 1999-05-13 2000-05-12 METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY IL146454A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/311,428 US6927034B2 (en) 1998-02-03 1999-05-13 Methods for detecting trophoblast malignancy by HCG assay
PCT/US2000/013197 WO2000070094A1 (en) 1999-05-13 2000-05-12 METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY

Publications (1)

Publication Number Publication Date
IL146454A0 true IL146454A0 (en) 2002-07-25

Family

ID=23206832

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14645400A IL146454A0 (en) 1999-05-13 2000-05-12 METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY
IL146454A IL146454A (en) 1999-05-13 2001-11-12 Methods for predicting pregnancy outcomes are tested by HCG

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL146454A IL146454A (en) 1999-05-13 2001-11-12 Methods for predicting pregnancy outcomes are tested by HCG

Country Status (9)

Country Link
US (8) US6927034B2 (xx)
EP (1) EP1183390B8 (xx)
AT (1) ATE395812T1 (xx)
AU (1) AU778130B2 (xx)
CA (1) CA2372666C (xx)
DE (1) DE60025347T2 (xx)
IL (2) IL146454A0 (xx)
NZ (1) NZ516024A (xx)
WO (1) WO2000070094A1 (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500627B1 (en) 1998-02-03 2002-12-31 The Trustees Of Columbia University In The City Of New York Methods for predicting pregnancy outcome in a subject by HCG assay
US7198954B1 (en) 1999-02-03 2007-04-03 The Trustees Of Columbia University In The City Of New York Methods for predicting pregnancy outcome in a subject by hCG assay
US6927034B2 (en) * 1998-02-03 2005-08-09 The Trustees Of Columbia University In The City Of New York Methods for detecting trophoblast malignancy by HCG assay
JP2001349892A (ja) * 2000-04-03 2001-12-21 Unilever Nv 検査方法及びデバイス
US20030027234A1 (en) * 2001-07-30 2003-02-06 Pandian Murugan R. Methods for detecting Down's syndrome
US6627457B2 (en) 2001-07-30 2003-09-30 Quest Diagnostics Investments Incorporated Methods for detecting pregnancy
WO2003012445A1 (en) 2001-07-30 2003-02-13 Quest Diagnostics Investments Incorporated Methods and kits for detecting ita in a biological sample
US7871762B2 (en) * 2002-10-10 2011-01-18 Stc.Unm Hyperglycosylated hCG (invasive trophoblast antigen) in differential diagnosis of malignant or invasive trophoblastic disease
US7572639B2 (en) * 2004-06-03 2009-08-11 Stc.Unm Method and apparatus for predicting pregnancy outcome
US20060105411A1 (en) * 2004-11-15 2006-05-18 Cole Laurence A Method of detecting early pregnancy at high accuracy by measuring hCG and hyperglycosylated hCG concentrations equally
CA2615460A1 (en) * 2005-08-08 2007-02-15 Onconon, Llc Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
AU2007242587A1 (en) * 2006-04-21 2007-11-01 British Pregnancy Advisory Service Device and method for detection of a pregnancy associated hormone
US20080182244A1 (en) * 2006-08-04 2008-07-31 Ikonisys, Inc. Pre-Implantation Genetic Diagnosis Test
US8989764B2 (en) * 2007-09-05 2015-03-24 The University Of Utah Research Foundation Robust location distinction using temporal link signatures
WO2010030950A2 (en) * 2008-09-12 2010-03-18 University Of Utah Research Foundation Method and system for detecting unauthorized wireless access points using clock skews
US8818288B2 (en) * 2010-07-09 2014-08-26 University Of Utah Research Foundation Statistical inversion method and system for device-free localization in RF sensor networks
MX342210B (es) * 2010-07-13 2016-09-20 Univfy Inc * Metodo para evaluar el riesgo de nacimientos multiples en tratamientos de infertilidad.
US10271876B2 (en) 2011-11-23 2019-04-30 Mezadata Medical Ip Holding Llc Method of in vitro fertilization with delay of embryo transfer and use of peripheral blood mononuclear cells
US8999728B2 (en) * 2011-12-21 2015-04-07 Church & Dwight Co., Inc. Diagnostic detection device
US9177098B2 (en) 2012-10-17 2015-11-03 Celmatix Inc. Systems and methods for determining the probability of a pregnancy at a selected point in time
EP3221444B1 (en) * 2014-11-18 2022-03-02 Siemens Healthcare Diagnostics Inc. Lateral flow assay ratio test
WO2018187585A1 (en) * 2017-04-06 2018-10-11 Celmatix Inc. Methods for assessing the potential for reproductive success and informing treatment therefrom
US10603075B1 (en) 2018-11-30 2020-03-31 Ohana Biosciences, Inc. Compositions and methods for enhancing sperm function
WO2024037724A1 (en) 2022-08-19 2024-02-22 Consejo Nacional De Investigaciones Científicas Y Técnicas (Conicet) Methods for improving sperm function and fertilizing ability for assisted reproduction techniques

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
US4514505A (en) 1982-05-21 1985-04-30 The Trustees Of Columbia University In The City Of New York Monoclonal antibody mixtures and use thereof for enhanced sensitivity immunoassays
JPH02501160A (ja) 1986-12-22 1990-04-19 ユニバーシティー　オブ　クイーンスランド 早期妊娠因子（ｅｐｆ）に対する抗体を使用する哺乳動物の治療方法
US5260421A (en) 1987-12-21 1993-11-09 Applied Research Systems Ars Holding N.V. Site-directed mutagenesis modified glycoprotein hormones
EP0553301A1 (en) 1990-10-17 1993-08-04 Yale University Methods for detecting and following the course of cancer, pregnancy and trophoblastic disease
JPH04300896A (ja) 1991-03-29 1992-10-23 Hiroshi Sueoka ヒト由来の早期妊娠因子及びその分離・精製法
US6339143B1 (en) * 1993-05-13 2002-01-15 The Trustees Of Columbia University In The City Of New York Methods of using antibodies against hormone-related determinants
EP1992944A1 (en) * 1996-09-06 2008-11-19 Yale University Prenatal screening for down's syndrome using hyperglycosylated gonadotropin
EP0833157B1 (en) 1996-09-27 2002-11-20 Inverness Medical Switzerland GmbH Assay reagents and devices
US6927034B2 (en) 1998-02-03 2005-08-09 The Trustees Of Columbia University In The City Of New York Methods for detecting trophoblast malignancy by HCG assay
US6500627B1 (en) * 1998-02-03 2002-12-31 The Trustees Of Columbia University In The City Of New York Methods for predicting pregnancy outcome in a subject by HCG assay
US7198954B1 (en) * 1999-02-03 2007-04-03 The Trustees Of Columbia University In The City Of New York Methods for predicting pregnancy outcome in a subject by hCG assay
US6627457B2 (en) * 2001-07-30 2003-09-30 Quest Diagnostics Investments Incorporated Methods for detecting pregnancy
KR101301979B1 (ko) 2010-12-21 2013-08-30 주식회사 케이티 근거리 통신을 위한 액세스 포인트를 이용한 위치 측정 방법 및 장치와 액세스 포인트의 위치 추정 방법

Also Published As

Publication number Publication date
US20110159526A1 (en) 2011-06-30
CA2372666C (en) 2010-02-09
US8420339B2 (en) 2013-04-16
US20030003597A1 (en) 2003-01-02
IL146454A (en) 2007-10-31
AU778130B2 (en) 2004-11-18
US20080108089A1 (en) 2008-05-08
US20050042702A1 (en) 2005-02-24
US20150010926A1 (en) 2015-01-08
EP1183390B1 (en) 2006-01-04
NZ516024A (en) 2004-03-26
ATE395812T1 (de) 2006-01-15
US7790403B2 (en) 2010-09-07
WO2000070094A1 (en) 2000-11-23
US20110300557A1 (en) 2011-12-08
EP1183390A1 (en) 2002-03-06
EP1183390B8 (en) 2006-05-03
US8802381B2 (en) 2014-08-12
US20140087393A1 (en) 2014-03-27
US8163508B2 (en) 2012-04-24
DE60025347D1 (de) 2006-03-30
DE60025347T2 (de) 2006-09-14
AU5133400A (en) 2000-12-05
US7993858B2 (en) 2011-08-09
EP1183390A4 (en) 2003-05-07
CA2372666A1 (en) 2000-11-23
US7285391B2 (en) 2007-10-23
US6927034B2 (en) 2005-08-09
US20130011858A1 (en) 2013-01-10

Similar Documents

Publication Publication Date Title
WO1999041584A3 (en) METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY
IL146454A0 (en) METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY
WO2003043487A3 (en) Method of using a non-antibody protein to detect and measure an analyte
WO2002083918A3 (en) Novel microarrays and methods of use thereof
WO2002035232A3 (en) Method for detecting ovarian cancer based on human kallikrein 6 (hk6)
RU2008136193A (ru) Детектирование рака по повышенным уровням bcl-2
HK1078096A1 (en) Assay and reagents for quantifying hbnp
WO2007040559A3 (en) Electrochemiluminescent assay
Xiong et al. Use of a lectin affinity selector in the search for unusual glycosylation in proteomics
DE602006021777D1 (de) Diagnoseverfahren für präeklampsie
Darwish et al. Novel automated flow-based immunosensor for real-time measurement of the breast cancer biomarker CA15-3 in serum
WO2003106964A3 (en) HIGH EFFICIENCY METHODS AND DEVICES FOR ASSAYING ANALYTES IN A FLUID SAMPLE
WO2002037112A3 (en) Detection of ovarian cancer
EP1571160A4 (en) KIT FOR THE STUDY OF HUMAN LOW MOLECULAR WEIGHT CD14 AND ANTIBODIES
DE60232248D1 (de) Schwangerschaftsnachweisverfahren
WO2006004958A3 (en) Detection or measurement of antibodies to antigenic proteins in biological tissues or samples
WO2003016907A1 (fr) Reactif de dosage pour antigene de la laminine 5 dans un echantillon biologique et procede de dosage
WO2003046140A3 (en) Immunoassay and kit for an early and simulataneous detection of biochemical markers in a patient's sample
WO2005019831B1 (en) Methods for reducing complexity of a sample using small epitope antibodies
WO2001021826A3 (de) Nachweis des pyruvatkinase-isoenzyms im stuhl
WO2001075449A1 (fr) Technique d'investigation du cancer par epreuve biologique d'un autoanticorps contre mdm2 et reactif
EP1059533A4 (en) METHOD FOR THE IMMUNOLOGICAL DETECTION OF ANTI-HM1.24 ANTIBODY
EP1476757A4 (en) METHOD AND KIT FOR PREDICTING CANCER
WO2003100079A3 (en) Method of analyzing proenzyme forms of prostate specific antigen in serum to improve prostate cancer detection
EP1245957A3 (en) Method of measuring ceruloplasmin concentration with enzyme-linked immunosorbent assay or dissociation-enhanced time-resolved fluoroimmunoassay in a blood spot, and Wilson's disease screening kit and method of diagnosing Wilson's disease

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed